XM无法为美国居民提供服务。

XM无法为美国居民提供服务。
P
P

Pfizer

市场新闻

Reuters - 18小时前

Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)

CORRECTED-Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17) Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory infections, not all lower respiratory infections Oct 17 (Reuters) - Merck MRK.N said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory syncytial virus (RSV)-associated infections in infants.
A
P
S
S
Reuters - 21小时前

Consumer groups ask FTC to block Novo Holdings-Catalent deal

UPDATE 6-Consumer groups ask FTC to block Novo Holdings-Catalent deal Consumer groups and unions express competition concerns to FTC Deal could limit options for competitors developing GLP-1 drugs Concerns also raised about impact on gene therapy manufacturing Adds Novo Nordisk comment in paragraph 13 By Jody Godoy and Maggie Fick NEW YORK, Oct 18 (Reuters) - U.S.
A
A
N
N
P
R
Reuters - 22小时前

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Consumer groups ask FTC to block Novo Holdings-Catalent deal Consumer groups and unions express competition concerns to FTC Deal could limit options for competitors developing GLP-1 drugs Concerns also raised about impact on gene therapy manufacturing By Jody Godoy, Maggie Fick NEW YORK, Oct 17 (Reuters) - Five U.S. consumer groups and two large labor unions urged the U.S.
A
A
N
N
P
R
Reuters - 2天前

Northwestern sues Moderna for patent infringement over 19 vaccines

Northwestern sues Moderna for patent infringement over COVID-19 vaccines By Blake Brittain Oct 16 (Reuters) - Moderna MRNA.O was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the school's innovations to develop its blockbuster COVID-19 vaccine Spikevax. The lawsuit said Moderna uses Northwestern-developed lipid nanoparticle (LNP) technology without a license in Spikevax shots to transport fragile messenger
G
P
Reuters - 2天前

US FDA pauses Novavax's trial of combo flu shot on safety concerns

UPDATE 4-US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns Adds analyst comment in paragraphs 7 and 11; Sanofi's response in paragraph 10 By Bhanvi Satija Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's NVAX.O COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage, the company said on Wednesday.
P
S
Reuters - 3天前

An Van Gerven Is Appointed President Of Pfizer Canada

BRIEF-An Van Gerven Is Appointed President Of Pfizer Canada Oct 15 (Reuters) - Pfizer Canada: AN VAN GERVEN IS APPOINTED PRESIDENT OF PFIZER CANADA Source text for Eikon: ID:nCNW9TK6Ba Further company coverage: []
P
Reuters - 3天前

GSK sues Moderna for US patent infringement over COVID, RSV vaccines

UPDATE 2-GSK sues Moderna for US patent infringement over COVID, RSV vaccines Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna Adds information about RSV vaccine claims in paragraphs 1 and 6 By Blake Brittain Oct 15 (Reuters) - British drugmaker GlaxoSmithKline GSK.L sued Moderna MRNA.O in U.S.
G
N
P
Reuters - 3天前

Pfizer taps Vanguard veteran for board amid fight with Starboard

Pfizer taps Vanguard veteran for board amid fight with Starboard By Svea Herbst-Bayliss NEW YORK, Oct 15 (Reuters) - Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value. Mortimer "Tim" Buckley served as Vanguard's chairman and chief executive until this year when he announced his retirement.
P
Reuters - 3天前

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines Oct 15 (Reuters) - GlaxoSmithKline GLAX.NS sued Moderna MRNA.O in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax. The lawsuit said Moderna's lipid nanoparticles for transporting mRNA into the human body infringe several GSK patents covering similar innovations.
P
Reuters - 4天前

U.S. stocks weekly: Birthday bull

REFILE-RPT-BUZZ-U.S. stocks weekly: Birthday bull Repeats from Friday with no changes, refiles to adjust format ** S&P 500 .SPX advances fifth straight week, adds 1.1% as earnings season gets underway .N ** This as the bull market hits a birthday , and it still may be young at heart ** Indeed, SPX scores new highs, and has now posted its 45th record closing high so far this year ** Benchmark U.S.
C
G
J
N
P
P
T
U
U
A
G
U
Reuters - 1周前

U.S. stocks weekly: Birthday bull

BUZZ-U.S. stocks weekly: Birthday bull ** S&P 500 .SPX advances fifth straight week, adds 1.1% as earnings season gets underway .N ** This as the bull market hits a birthday , and it still may be young at heart ** Indeed, SPX scores new highs, and has now posted its 45th record closing high so far this year ** Benchmark U.S. 10-year Treasury yield US10YT=RR forges back over 4%, but streak may have it stretched to the upside ** Majority of sectors celebrate: Technology and Industrials party most,
C
G
J
N
P
P
T
U
U
A
G
U
Reuters - 1周前

US FDA approves Pfizer's drug for rare bleeding disorder

UPDATE 2-US FDA approves Pfizer's drug for rare bleeding disorder Adds analyst estimates in paragraph 6, trial details in paragraph 8, and other treatments in paragraph 5, 10 and 11 By Sruthi Narasimha Chari and Christy Santhosh Oct 11 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's PFE.N once-a-week injection for the two main types of a rare bleeding disorder called hemophilia, the company said on Friday.
B
P
S
Reuters - 1周前

US FDA approves Pfizer's drug for rare bleeding disorder

US FDA approves Pfizer's drug for rare bleeding disorder Oct 11 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's PFE.N once-a-week injection for the two main types of a rare bleeding disorder called hemophilia, the company said on Friday. Reporting by Sruthi Narasimha Chari and Christy Santhosh in Bengaluru; Editing by Vijay Kish
B
P
S
Reuters - 1周前

Evonik to scale back adhesives, health care units in restructuring

UPDATE 2-Evonik to scale back adhesives, health care units in restructuring CEO says company must adjust to industry changes German site with 260 staff to close Non-core areas to be discontinued Adds details in paragraphs 3-6 BERLIN, Oct 11 (Reuters) - Germany's Evonik will scale back its adhesives and health care lines to focus on core assets, it said on Friday, shedding other operations including a polyester business and a production line for keto acids in Hanau.
P
Reuters - 1周前

Sanofi in talks to sell 50% stake in consumer health business to CD&R

UPDATE 2-Sanofi in talks to sell 50% stake in consumer health business to CD&R Adds French finance ministry comments in paragraphs 7-9 PARIS, Oct 11 (Reuters) - Sanofi SASY.PA has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical group said on Friday.
P
S
Reuters - 1周前

US judicial panel to examine litigation finance disclosure

UPDATE 1-US judicial panel to examine litigation finance disclosure Adds comment from litigation funding group in paragraph 16 By Nate Raymond Oct 10 (Reuters) - A federal judicial rules-making panel on Thursday agreed to study whether a nationwide rule requiring disclosure of third-party litigation funding in lawsuits is necessary at the urging of major companies, business groups and Republican lawmakers .
A
B
C
G
N
P
Reuters - 1周前

US judicial panel to examine litigation finance disclosure

US judicial panel to examine litigation finance disclosure By Nate Raymond Oct 10 (Reuters) - A federal judicial rules-making panel on Thursday agreed to study whether a nationwide rule requiring disclosure of third-party litigation funding in lawsuits is necessary at the urging of major companies, business groups and Republican lawmakers . After a decade of weighing whether it should do anything to regulate the emerging field of litigation finance, the U.S.
A
B
C
G
N
P
Reuters - 1周前

Wall Street ends slightly lower after higher than expected inflation, jobless claims

US STOCKS-Wall Street ends slightly lower after higher than expected inflation, jobless claims September CPI data higher than expected Unemployment claims higher than estimates Delta Air Lines shares fall after Q3 results Energy stocks track oil prices higher Banks to kick off Q3 earnings season on Friday Indexes: Dow down 0.14%, S&P 500 off 0.21, Nasdaq down 0.05% Updated with final closing prices, volume By Sinéad Carew and Lisa Pauline Mattackal Oct 10 (Reuters) - Wall Street's main indexes
P
A
U
U
U
Reuters - 1周前

Wall Street ends slightly lower after higher than expected inflation, unemployment

US STOCKS-Wall Street ends slightly lower after higher than expected inflation, unemployment Updated with preliminary closing prices at 4:00 p.m ET/ 2000 GMT By Sinéad Carew and Lisa Pauline Mattackal Oct 10 (Reuters) - Wall Street's main indexes closed lower on Thursday as investors looked to higher-than-expected inflation and unemployment claims for indications on the health of the U.S.
P
A
U
U
U
Reuters - 1周前

Wall Street dips slightly after higher than expected inflation, unemployment

US STOCKS-Wall Street dips slightly after higher than expected inflation, unemployment September CPI data higher than expected Delta Air Lines down after Q3 results Energy stocks track oil prices higher Banks to kick off Q3 earnings season on Friday Indexes: Dow down 0.34%, S&P 500 off 0.30, Nasdaq down 0.17% Updates prices at 2:23 p.m ET / 1823 GMT By Sinéad Carew and Lisa Pauline Mattackal Oct 10 (Reuters) - Wall Street's main indexes were slightly lower on Thursday as investors looked to hig
P
A
U
U
U

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。

风险提示： 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明。